Nasdaq

In a strategic shift that has captured Wall Street's attention, Warren Buffett's Berkshire Hathaway has established a substantial position in...

The publicly traded journey of G1 Therapeutics has reached its conclusion. The biotechnology firm ceased trading on the NASDAQ effective...

The cybersecurity sector appears poised for unprecedented expansion, yet the ProShares Ultra Nasdaq Cybersecurity ETF (UCYB) presents investors with a...

Intellia Therapeutics, a prominent player in the gene-editing sector, is confronting a severe crisis after a fatality occurred in a...

A significant regulatory milestone in Arizona and expanded public testing in Texas are accelerating Tesla's autonomous vehicle strategy, even as...

While much of the technology sector remains captivated by the narratives surrounding Nvidia and AMD, Micron Technology is orchestrating a...

Adobe's stock touched a new annual low during Tuesday's trading session, reflecting a combination of broad technology sector weakness and...

The market delivered a surprising verdict on Palantir Technologies this week, with shares declining 2.29% on Tuesday despite the company...

The corporate saga of Shiftpixy has reached its conclusive phase, with the company now undergoing complete liquidation following its bankruptcy...

The stock of Adobe, a dominant force in the software industry renowned for its creative suites including Photoshop and Premiere,...